课题基金 / 基金详情

CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS

CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
儿童失神癫痫：RX、PK-PD-药物遗传学
批准号：
7606548
负责人：
DORIS A TRAUNER
金额：
$3.14万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606548
关键词：
Absence EpilepsyAnticonvulsantsChildComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantIncidenceInstitutionPharmacogeneticsRateResearchResearch PersonnelResourcesSeizuresSourceToxic effectUnited States National Institutes of Health

项目摘要

项目成果

DORIS A TRAUNER的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To identify the optimal anticonvulsant (i.e. the AED with the highest rate of seizure control and lowest incidence of treatment limiting toxicity) used for the initial treatment of children with Childhood Absence Epilepsy (CAE).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
海外基金